Аннотация:
The effect of neuroprotectors is directed to the key components of nerve cell destructive processes of vascular, traumatic, or toxic etiologies. Phosphatidylcholines, gingko biloba-based agents, and a combination of B vitamins and folic acid, which are contained in Cerebrovin, may act as a neuroprotector. Objective — to reveal the possible effect of Cerebrovin on the degree of decline in cognitive functions and motor dexterity, including a typing speed test. Subject and methods. Patients with chronic cerebral ischemia (CCI) with mild and moderate cognitive impairment (MiCI and MoCI) were followed up. The Montreal Cognitive Assessment (MoCA), the Münsterberg test, the Trail Making Test (TMT), and original hand motor dexterity tests were used. The investigation enrolled 30 patients aged 55—75 years (mean age, 68.0±5.4 years) with CCI. All the participants were divided into two groups: 1) MiCI (n=18) and 2) MoCI (n=12). One or two Cerebrovin tablets were daily given during 4 weeks for MiC
Ключевые слова:
Cerebrovin; Chronic cerebral ischemia; Cognitive impairment; Neuroprotectors
cerebrovin; folic acid; Ginkgo biloba extract; neuroprotective agent; unclassified drug; vitamin B group; adult; aged; Article; brain ischemia; clinical article; cognitive defect; combination drug therapy; controlled study; dementia assessment; dexterity test; follow up; human; mental deterioration; Montreal cognitive assessment; Munsterberg test; neuroprotection; outpatient care; tablet; trail making test; treatment duration
Шавловская О. А. Ольга Александровна 1970-
Локшина А. Б. Анастасия Борисовна 1975-
Гришина Д. А. Динара Александровна 1978-
Shavlovskaya O. A. Ol`ga Aleksandrovna 1970-
Lokshina A. B. Anastasiya Borisovna 1975-
Grishina D. A. Dinara Aleksandrovna 1978-
Prevention of cognitive impairment in patients with cerebrovascular disease
Текст визуальный непосредственный
Профилактическая медицина
Издательство Медиа Сфера
Т. 22, Вып. 2 С. 89-94
2019
Статья
Cerebrovin Chronic cerebral ischemia Cognitive impairment Neuroprotectors
cerebrovin folic acid Ginkgo biloba extract neuroprotective agent unclassified drug vitamin B group adult aged Article brain ischemia clinical article cognitive defect combination drug therapy controlled study dementia assessment dexterity test follow up human mental deterioration Montreal cognitive assessment Munsterberg test neuroprotection outpatient care tablet trail making test treatment duration
The effect of neuroprotectors is directed to the key components of nerve cell destructive processes of vascular, traumatic, or toxic etiologies. Phosphatidylcholines, gingko biloba-based agents, and a combination of B vitamins and folic acid, which are contained in Cerebrovin, may act as a neuroprotector. Objective — to reveal the possible effect of Cerebrovin on the degree of decline in cognitive functions and motor dexterity, including a typing speed test. Subject and methods. Patients with chronic cerebral ischemia (CCI) with mild and moderate cognitive impairment (MiCI and MoCI) were followed up. The Montreal Cognitive Assessment (MoCA), the Münsterberg test, the Trail Making Test (TMT), and original hand motor dexterity tests were used. The investigation enrolled 30 patients aged 55—75 years (mean age, 68.0±5.4 years) with CCI. All the participants were divided into two groups: 1) MiCI (n=18) and 2) MoCI (n=12). One or two Cerebrovin tablets were daily given during 4 weeks for MiC